Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-16-048046
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-01 13:11:15
Reporting Period:
2016-03-30
Filing Date:
2016-04-01
Accepted Time:
2016-04-01 13:11:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920148 Laboratory Corp Of America Holdings LH Services-Medical Laboratories (8071) 133757370
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454748 Jr. T. James Boyle 531 South Spring Street
Burlington NC 27215
Evp,ceo Of Labcorp Diagnostics No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-30 34,737 $0.00 58,191 No 4 A Direct
Common Stock Disposition 2016-03-30 16,605 $117.85 41,586 No 4 F Direct
Common Stock Disposition 2016-03-31 13,191 $116.67 28,395 No 4 S Direct
Common Stock Disposition 2016-03-31 4,941 $117.19 23,454 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares acquired on March 30, 2016, pursuant to a performance award granted on February 12, 2013, relating to performance during the three-year period ended December 31, 2015.
  2. Stock withholding to satisfy tax withholding obligations.
  3. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
  4. The price of $116.67 per share represents a weighted average of sales prices ranging from $116.10 to $117.09 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  5. The price of $117.19 per share represents a weighted average of sales prices ranging from $117.10 to $117.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.